Cryo-Save Group N.V. - Share buyback tranche successfully completed
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading
international stem cell storage company and the largest family stem cell bank in
Europe, announces that it has completed the tranche of its share buyback
programme as announced on 30 January 2013.
The Group has purchased 1,597 shares and has reached an agreement with a
shareholder regarding the buyback of 120,000 shares via its bank Kempen & Co.
The share purchase and the block trade are part of the share buyback programme
as announced yesterday. Cryo-Save repurchased these 121,597 shares at an average
price of â‚¬ 2.34.
These shares together with the 364,000 treasury shares that are already in the
possession of the Group, representing 5% of the issued shares, will be proposed
for cancellation by the Board at the upcoming Annual General Meeting on 15 May
Cryo-Save Group, Arnoud van Tulder, Chief Executive Officer + 31 (0)
575 509 100
Please click here for full press release in PDF:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE